Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study

Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study

Background Catheter-related bladder discomfort (CRBD) is a frequent complaint after awakening from anesthesia in patients receiving perioperative bladder catheterization. Overactive bladder (OAB) and CRBD show similar symptoms; thus, drugs used for the management of OAB influence symptoms of CRBD. T...

Full description

Bibliographic Details
Main Authors:	Vinit Kumar Srivastava, Sanjay Agrawal, Sweta Anil Deshmukh, Febin Noushad, Saima Khan, Raj Kumar
Format:	Article
Language:	English
Published:	Korean Society of Anesthesiologists 2020-04-01
Series:	Korean Journal of Anesthesiology
Subjects:	antimuscarinic muscarinic antagonists muscarinic receptors overactive bladder postoperative period trospium chloride urinary catheterization
Online Access:	http://ekja.org/upload/pdf/kja-19198.pdf

Similar Items

Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
by: Hee Seo Son, et al.
Published: (2022-06-01)

Protective Effects of Antimuscarinics on the Bladder Remodeling After Bladder Outlet Obstruction
by: Qiang Liu, et al.
Published: (2017-11-01)

Guidelines for the Treatment of Urinary Incontineence and Overactive Bladder
by: C.F. Heyns, et al.
Published: (2002-03-01)

Literature Review: Efektivitas, Keamanan, dan Biaya Terapi Imidafenacin untuk Pasien Overactive Bladder
by: Steven Victoria Halim
Published: (2020-12-01)

The effects of oral administration of the novel muscarinic receptor antagonist DA-8010 on overactive bladder in rat with bladder outlet obstruction
by: Jin Bong Choi, et al.
Published: (2020-04-01)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
by: Jaromir Myslivecek
Published: (2022-09-01)

Persistence and compliance with medication management in the treatment of overactive bladder
by: Tae Heon Kim, et al.
Published: (2016-03-01)

Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study
by: Myungsun Shim, et al.
Published: (2020-11-01)

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin
by: Marloes J. Tijnagel, et al.
Published: (2017-04-01)

Trospium chloride in children: dynamic changes of the residual urine symptom during treatment of urination disorders
by: Vadim. V. Danilov, et al.
Published: (2024-03-01)

Masks of Chronic Prostatitis: Overactive bladder and Myofascial Syndrome. Case study
by: E. V. Kulchavenya, et al.
Published: (2019-09-01)

Overactive bladder – 18 years – Part II
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
by: Abdul Aziz MI, et al.
Published: (2018-10-01)

The effectiveness of intravesical oxybutynin in the management of overactive bladder: a clinical study
by: Shoeb Alahmad, et al.
Published: (2024-12-01)

Factors of adherence to treatment with trospium in employees
by: Kirill Vladimirovich Kosilov, et al.
Published: (2017-09-01)

Bladder and bowel: friends or enemies?
by: Ekaterina V. Kulchavenia
Published: (2020-03-01)

Biochemical studies on muscarinic cholinergic receptors
by: Carson, S
Published: (1982)

Dementia patients have greater anti-cholinergic drug burden on discharge from hospital: A multicentre cross-sectional study
by: J. Randall, et al.
Published: (2021-04-01)

Long-Term Efficacy of Mirabegron Add-On Therapy to Antimuscarinic Agents in Patients With Spinal Cord Injury
by: Seok-Hee Han, et al.
Published: (2019-02-01)

Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
by: Ji-Su Shim, MD, PhD, et al.
Published: (2022-12-01)

Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models
by: Luigino Calzetta, et al.
Published: (2022-06-01)

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study
by: Jutta Beier, et al.
Published: (2013-08-01)

The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline–Trospium Combination: A Systematic Review
by: Octavian Vasiliu, et al.
Published: (2024-05-01)

Heart rate responses to a muscarinic agonist in rats with experimentally induced acute and subacute chagasic myocarditis
by: Argenis TORRES, et al.
Published: (2000-08-01)

Involvement of muscarinic receptors in psychomotor hyperactivity in dopamine-deficient mice
by: Masayo Fujita, et al.
Published: (2022-11-01)

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study
by: Beier J, et al.
Published: (2017-06-01)

The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
by: Tomonori Yamanishi, et al.
Published: (2015-06-01)

Comparative persistence, switch rates, and predictors for discontinuation of antimuscarinics for overactive bladder: A 10-year nationwide population-based study in Taiwan
by: Hao-Wei Chen, et al.
Published: (2018-01-01)

Reduction in exacerbation of COPD in patients of advanced age using the Japanese Kampo medicine Dai-kenchu-to: a retrospective cohort study
by: Jo T, et al.
Published: (2018-12-01)

Preliminary study of the efficacy of the combination of tamsulosin and trospium as a medical expulsive therapy for distal ureteric stones
by: A.S. Abdelaziz, et al.
Published: (2017-03-01)

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
by: Nalini Jayanthi, et al.
Published: (2022-08-01)

Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
by: Hann-Chorng Kuo, et al.
Published: (2015-03-01)

Patterns of bronchodilator therapy in asthmatic outpatients
by: Toetik Aryani, et al.
Published: (2023-03-01)

A Universal Pharmacological-Based List of Drugs with Anticholinergic Activity
by: Marta Lavrador, et al.
Published: (2023-01-01)

Patterns and Trends in the Use of Medications for COPD Control in a Cohort of 9476 Colombian Patients, 2017–2019
by: Machado-Duque ME, et al.
Published: (2023-07-01)

A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
by: Feldman G, et al.
Published: (2016-04-01)

Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis
by: James F. Donohue, et al.
Published: (2020-05-01)

Predictive Factors of Endotracheal Intubation in Poisoned Patients with Organophosphates
by: Nastaran Eizadi-Mood, et al.
Published: (2011-10-01)

IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia
by: Brian Dean
Published: (2024-12-01)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
by: Luisa Gracio Ferreira Sartori, et al.
Published: (2023-08-01)